BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced that at BIND’s annual meeting of stockholders held today the company’s stockholders elected Mr. Charles A. Rowland, Jr., CPA, most recently the … Continued
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, announced today that clinical data on its lead drug candidate, BIND-014, were presented at the American Association of Cancer Research (AACR) meeting. The … Continued
Twist Bioscience today announced that it raised $26 million in a Series B financing to commercialize the company’s semiconductor-based synthetic gene manufacturing process. Nick and Joby Pritzker, through their family’s firm Tao Invest, led the round, with participation from ARCH … Continued
ARMO BioSciences, Inc., a clinical-stage biotechnology company, today announced it raised $30 million in a Series B private financing led by NanoDimension. Existing investors Kleiner Perkins Caufield & Byers, OrbiMed and DAG Ventures also participated in the round. “This financing … Continued
Crocus Technology, a leading developer of magnetically enhanced semiconductor technologies for mobile security, embedded microcontrollers, harsh environment electronics and magnetic sensors, today announces it has licensed its Magnetic Logic Unit™ (MLU™) technology to ARM®. Magnetic Logic Unit™ (MLU) is a … Continued
ARM® and Crocus Technology today announce that Crocus has licensed the ARM SecurCore® SC000 ™ processor. Crocus’s new range of secure microcontrollers will combine SecurCore technology with Crocus’s innovative Magnetic Logic Unit™ (MLU) architecture. The combined strengths of these two … Continued
View CEO Rao Mulpuri discusses how to treat employees, care for customers and to learn on Fortune’s 10 Questions. Fortune
MILPITAS, Calif. (January 7, 2013) – View, the leader in dynamic glass, today announced a $100 million investment from Madrone Capital Partners. The investment will enable the company to extend its market leadership and meet increasing demand for View Dynamic … Continued